World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
111
Citations
46258
World Ranking
472
National Ranking
288

Medicine

D-Index
111
Citations
46350
World Ranking
5327
National Ranking
2877

Edgar G. Engleman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Edgar G. Engleman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 389 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Edgar G. Engleman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Edgar G. Engleman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 111 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Edgar G. Engleman is affiliated with Stanford University in the United States. Their research spans several interconnected fields, primarily within immunology, microbiology, and medicine. The work focuses extensively on cancer immunotherapy, immune responses, and molecular biology.

The main fields of study for Engleman include:

  • Immunology and Microbiology
  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, Engleman's research covers various subfields such as:

  • Immunology
  • Oncology
  • Molecular Biology
  • Cell Biology
  • Hematology

The primary topics of Engleman's scientific contributions involve:

  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Immune Cell Function and Interaction
  • Single-cell and spatial transcriptomics
  • Glycosylation and Glycoproteins Research

Engleman has contributed to multiple research publications with notable recent papers including:

  • "Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" (2020) published in Annual Review of Pathology Mechanisms of Disease
  • "Lymph node colonization induces tumor-immune tolerance to promote distant metastasis" (2022) published in Cell
  • "Mechanical Stiffness Controls Dendritic Cell Metabolism and Function" (2021) published in Cell Reports
  • "Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity" (2020) published in Nature Cancer
  • "Neutrophil-activating therapy for the treatment of cancer" (2023) published in Cancer Cell

Frequent collaborators in Engleman's research include:

  • Nathan E. Reticker-Flynn
  • Weiruo Zhang
  • Sylvia K. Plevritis
  • John B. Sunwoo
  • Andrew J. Gentles

Engleman's research is often published in these venues:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Regular and Young Investigator Award Abstracts
  • Nature
  • International Journal of Molecular Sciences

Best Publications

  • Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

    Frank J. Hsu;Claudia Benike;Francesco Fagnoni;Tina Marie Liles

  • Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance.

    Sreya Bagchi;Robert Yuan;Edgar G Engleman

  • Normalization of obesity-associated insulin resistance through immunotherapy.

    Shawn Winer;Yin Chan;Geoffrey Paltser;Dorothy Truong

  • Langerhans cells renew in the skin throughout life under steady-state conditions

    Miriam Merad;Markus G. Manz;Holger Karsunky;Amy Wagers

  • Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

    Lawrence Fong;Yafei Hou;Alberto Rivas;Claudia Benike

  • B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

    Daniel A Winer;Shawn Winer;Shawn Winer;Lei Shen;Persis P Wadia

  • Dendritic Cells in Cancer Immunotherapy

    Lawrence Fong;Edgar G. Engleman

  • Systemic Immunity Is Required for Effective Cancer Immunotherapy

    Matthew H. Spitzer;Yaron Carmi;Yaron Carmi;Nathan E. Reticker-Flynn;Serena S. Kwek

  • pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane

    Barry S. Stein;Barry S. Stein;Shantharaj D. Gowda;Shantharaj D. Gowda;Jeffrey D. Lifson;Jeffrey D. Lifson;Jeffrey D. Lifson;Robert C. Penhallow

  • Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

    Jeffrey D. Lifson;Jeffrey D. Lifson;Mark B. Feinberg;Gregory R. Reyes;Linda Rabin

  • AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen

    Jeffrey D. Lifson;Jeffrey D. Lifson;Gregory R. Reyes;Michael S. McGrath;Barry S. Stein;Barry S. Stein

  • Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

    John M. Timmerman;Debra K. Czerwinski;Thomas A. Davis;Frank J. Hsu

  • Tolerance and Chimerism after Renal and Hematopoietic-Cell Transplantation

    John D. Scandling;Stephan Busque;Sussan Dejbakhsh-Jones;Claudia Benike

  • Development of CD8α-Positive Dendritic Cells from a Common Myeloid Progenitor

    David Traver;Koichi Akashi;Markus Manz;Miriam Merad

  • Langerhans cells renew in the skin throughout life under steady-state conditions

    Unknown

  • Idiotype Vaccination Using Dendritic Cells After Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma—A Feasibility Study

    Volker L. Reichardt;Craig Y. Okada;Arcangelo Liso;Claudia J. Benike

  • Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.

    Alexander Filatenkov;Jeanette Baker;Antonia M.S. Mueller;Justin Kenkel

  • Dendritic Cells Injected Via Different Routes Induce Immunity in Cancer Patients

    Lawrence Fong;Dirk Brockstedt;Claudia Benike;Lijun Wu

  • Role of innate and adaptive immunity in obesity-associated metabolic disease

    Tracey McLaughlin;Shelley E. Ackerman;Lei Shen;Edgar Engleman

  • Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease

    Miriam Merad;Petra Hoffmann;Petra Hoffmann;Erik Ranheim;Sarah Slaymaker

  • Studies of a human T lymphocyte antigen recognized by a monoclonal antibody

    E G Engleman;R Warnke;R I Fox;J Dilley

Frequent Co-Authors

Samuel Strober
Samuel Strober Stanford University
Miriam Merad
Miriam Merad Icahn School of Medicine at Mount Sinai
Steven K. H. Foung
Steven K. H. Foung Stanford University
F. Carl Grumet
F. Carl Grumet Stanford University
Lawrence Fong
Lawrence Fong University of California, San Francisco
Ronald Levy
Ronald Levy Stanford University
Richard T. Hoppe
Richard T. Hoppe Stanford University
Judith A. Shizuru
Judith A. Shizuru Stanford University
Garry P. Nolan
Garry P. Nolan Stanford University
Markus G. Manz
Markus G. Manz University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare careers can provide diverse opportunities. Nursing pathways such as Licensed Practical Nurse (LPN) programs offer an accessible entry point to patient care. Many aspiring nurses seek out easy admission LPN programs to begin their education without extensive barriers, making it a practical choice for career changers or those new to healthcare.

For advanced practice roles, becoming a Nurse Practitioner (NP) is a common goal. Programs classified under easy nurse practitioner programs to get into provide flexible admission standards, helping more students progress quickly into specialized nursing fields.

Among NP specialties, Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are particularly relevant for those focusing on neuroimmune and mental health intersections. The top online PMHNP programs not only offer quality education but also ensure strong clinical placement rates, which are crucial for hands-on experience in mental health care.

Cost is another important factor for many students. Choosing from the cheapest online PMHNP certificate programs can make advanced training more accessible, helping professionals further their careers without overwhelming debt. Together, these education pathways complement Immunology studies, opening doors to impactful healthcare professions.

Best Scientists Citing Edgar G. Engleman

Trending Scientists

Recently Published Articles